Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis
Conclusions: In conclusion, this meta-analysis shows that cetuximab- and panitumumab-based chemotherapy have different toxicity profiles in terms of the rate of severe adverse events.Oncology
Source: Oncology - Category: Cancer & Oncology Source Type: research
More News: Acne | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Colorectal Cancer | Erbitux | Science | Skin | Study | Toxicology